Amgen has appointed Jonathan Peacock executive VP and chief financial officer with effect from 1 September. He will move to …

Healthcare communications agency Adventis Health has appointed three new account executives, one to each of its integrated business units. They …

A five-year study by scientists in the UK and US of the way genomes and cancer medicines interact has yielded …
Roche has posted average first half year results with pharma sales that showed only low single digit growth. They showed …
Abbott has posted a set of strong sales for the second quarter, buoyed by the integration of Solvay Pharmaceuticals and …

Genzyme has posted a decrease in sales for the second quarter as its manufacturing woes continue. The US-based biopharma company …
GSK has reported a loss for its second quarter due to litigation costs related to Avandia and other problems. In …
Chandler Chicco Companies (CCC) has appointed Sam Walmsley to the newly-created position of head of European social media. She will …

A buyer has been found for the services of UK online doctors portal OnMedica, which have been on hold since …
Johnson & Johnson has seen a modest increase in sales for the second quarter, buoyed primarily by international sales and …

In a hammer blow to Roche, an influential Food and Drug Administration vote has gone against its cancer drug Avastin. …

Surrey, UK-based communications agency Axon has appointed Natalie Henson as associate director. She re-joins the firm in a leadership role …
The British Pharmacology Society (BPS) is the primary UK learned society concerned with research into drugs and the way they …
The European Commission has announced a €6.4 billion investment in research and innovation in a range of scientific disciplines including …
The coalition government has proposed five areas, from increasing quality of life to preventing premature death, against which the success …
How long has your company been operating? Eden Biodesign is enjoying its tenth anniversary this year. How is your field …
Another week, another raft of bad news for Johnson & Johnson’s manufacturing division. With one production facility already shut down …
Bristol-Myers Squibb is recalling nearly 150,000 tablets of its anticoagulant product Coumadin distributed across the US because some of them …
Pfizer has been told by the FDA to suspend trials of its novel injectable biotherapeutic tanezumab for chronic low back …
A crop of facility announcements from Merck & Co, Emergent, Tianyin, Apicore and PPS offset more job loss news from …